Literature DB >> 26307078

Genotypic diversity, pathogenic potential and the resistance profile of Salmonella Typhimurium strains isolated from humans and food from 1983 to 2013 in Brazil.

Fernanda Almeida1, Marta Inês Cazentini Medeiros2, Dália Dos Prazeres Rodrigues3, Juliana Pfrimer Falcão1.   

Abstract

Salmonella enterica subsp. enterica serovar Typhimurium is one of the leading serovars that causes salmonellosis worldwide. However, few studies have molecularly characterized S. Typhimurium strains in Brazil. In this study, we genotyped 92 S. Typhimurium strains isolated from humans (43) and food (49) between 1983 and 2013 in Brazil using PFGE, multiple-locus variable number of tandem repeats analysis (MLVA) and enterobacterial repetitive intergenic consensus PCR (ERIC-PCR). Moreover, we assessed the frequency of 12 virulence markers by PCR and the resistance profile against 12 antimicrobials. More than 85.8% of the strains studied carried 11 of the virulence markers or more. Thirty-three strains (25%) were multidrug resistant (MDR). The 92 S. Typhimurium studied were grouped by PFGE as PFGE-A, PFGE-B1 and PFGE-B2; by MLVA as MLVA-A, MLVA-B1 and MLVA-B2; and, finally, by ERIC-PCR as ERIC-A and ERIC-B. The strains isolated from humans before the mid-1990s were allocated to all clusters. The strains isolated from humans after the mid-1990s were distributed in the PFGE-B1, MLVA-B1, MLVA-B2 and ERIC-A clusters. The strains isolated from food were distributed in all clusters, except in PFGE-B2. All typing results suggested that the S. Typhimurium strains of human clinical origin isolated before the mid-1990s were genetically more diverse, which might indicate the selection of a more adapted S. Typhimurium subtype after Salmonella Enteritidis became the most prevalent serovar in Brazil. Regarding strains isolated from food, the results suggest the current circulation of more than one subtype. Furthermore, the high frequency of virulence genes and the presence of MDR strains reinforces their potential hazard for humans and the risk of their presence in foods in Brazil.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26307078     DOI: 10.1099/jmm.0.000158

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

Review 1.  Virulence Factors in Salmonella Typhimurium: The Sagacity of a Bacterium.

Authors:  Anamaria M P Dos Santos; Rafaela G Ferrari; Carlos A Conte-Junior
Journal:  Curr Microbiol       Date:  2018-05-21       Impact factor: 2.188

Review 2.  Phenotypic and Genotypic Eligible Methods for Salmonella Typhimurium Source Tracking.

Authors:  Rafaela G Ferrari; Pedro H N Panzenhagen; Carlos A Conte-Junior
Journal:  Front Microbiol       Date:  2017-12-22       Impact factor: 5.640

3.  Insights about the epidemiology of Salmonella Typhimurium isolates from different sources in Brazil using comparative genomics.

Authors:  Amanda Ap Seribelli; Patrick da Silva; Marcelo Ferreira da Cruz; Fernanda de Almeida; Miliane R Frazão; Marta I C Medeiros; Dália Dos P Rodrigues; Jalusa D Kich; Leandro de Jesus Benevides; Siomar de C Soares; Marc W Allard; Juliana Pfrimer Falcão
Journal:  Gut Pathog       Date:  2021-04-28       Impact factor: 4.181

4.  Phylogenetic and antimicrobial resistance gene analysis of Salmonella Typhimurium strains isolated in Brazil by whole genome sequencing.

Authors:  Fernanda Almeida; Amanda Aparecida Seribelli; Marta Inês Cazentini Medeiros; Dália Dos Prazeres Rodrigues; Alessandro de MelloVarani; Yan Luo; Marc W Allard; Juliana Pfrimer Falcão
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

5.  Increasing prevalence and dissemination of invasive nontyphoidal Salmonella serotype Typhimurium with multidrug resistance in hospitalized patients from southern Brazil.

Authors:  Rafael Oliveira Dos Reis; Margarida Neves Souza; Maria Cristina Piccoli Cecconi; Loeci Timm; Nilo Ikuta; Daniel Simon; Jonas Michel Wolf; Vagner Ricardo Lunge
Journal:  Braz J Infect Dis       Date:  2018-09-18       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.